Phloretin Prevents Diabetic Cardiomyopathy by Dissociating Keap1/Nrf2 Complex and Inhibiting Oxidative Stress
Hyperglycemia induces chronic inflammation and oxidative stress in cardiomyocyte, which are the main pathological changes of diabetic cardiomyopathy (DCM). Treatment aimed at these processes may be beneficial in DCM. Phloretin (PHL), a promising natural product, has many pharmacological activities,...
Main Authors: | Yin Ying, Jiye Jin, Li Ye, Pingping Sun, Hui Wang, Xiaodong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00774/full |
Similar Items
-
Identification of a novel small-molecule Keap1–Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy
by: Cheng-Shi Jiang, et al.
Published: (2018-01-01) -
Phloretin suppresses neuroinflammation by autophagy-mediated Nrf2 activation in macrophages
by: Tess Dierckx, et al.
Published: (2021-07-01) -
The Molecular Pharmacology of Phloretin: Anti-Inflammatory Mechanisms of Action
by: Solomon Habtemariam
Published: (2023-01-01) -
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
by: Giovanni Tossetta, et al.
Published: (2023-06-01) -
Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma
by: Feilong Chen, et al.
Published: (2022-09-01)